Table of Contents Asia-Pacific Neurotherapeutic Drugs Market Report 2012-2023 1 Neurotherapeutic Drugs Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs by Product Category 1.2.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 Asia-Pacific Neurotherapeutic Drugs Market by Application/End Users 1.3.1 Asia-Pacific Neurotherapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 Asia-Pacific Neurotherapeutic Drugs Market by Region 1.4.1 Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Neurotherapeutic Drugs (2012-2023) 1.5.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific Neurotherapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca Merck 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 AstraZeneca Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 Asia-Pacific Neurotherapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific Neurotherapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific Neurotherapeutic Drugs Sales and Revenue by Type 4.2.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific Neurotherapeutic Drugs Sales and Revenue by Application 4.3.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) by Application 5 China Neurotherapeutic Drugs (Sales, Revenue and Price) 5.1 China Neurotherapeutic Drugs Sales and Value (2012-2017) 5.1.1 China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 China Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 5.3 China Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 6 Japan Neurotherapeutic Drugs (Sales, Revenue and Price) 6.1 Japan Neurotherapeutic Drugs Sales and Value (2012-2017) 6.1.1 Japan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Japan Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 6.3 Japan Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 7 South Korea Neurotherapeutic Drugs (Sales, Revenue and Price) 7.1 South Korea Neurotherapeutic Drugs Sales and Value (2012-2017) 7.1.1 South Korea Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Korea Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 7.3 South Korea Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 8 Taiwan Neurotherapeutic Drugs (Sales, Revenue and Price) 8.1 Taiwan Neurotherapeutic Drugs Sales and Value (2012-2017) 8.1.1 Taiwan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Taiwan Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 9 India Neurotherapeutic Drugs (Sales, Revenue and Price) 9.1 India Neurotherapeutic Drugs Sales and Value (2012-2017) 9.1.1 India Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 India Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 India Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 9.3 India Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 10 Southeast Asia Neurotherapeutic Drugs (Sales, Revenue and Price) 10.1 Southeast Asia Neurotherapeutic Drugs Sales and Value (2012-2017) 10.1.1 Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 11 Australia Neurotherapeutic Drugs (Sales, Revenue and Price) 11.1 Australia Neurotherapeutic Drugs Sales and Value (2012-2017) 11.1.1 Australia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Australia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Australia Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific Neurotherapeutic Drugs Market Forecast (2018-2023) 13.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific Neurotherapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific Neurotherapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Asia-Pacific Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Neurotherapeutic Drugs Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of Neurotherapeutic Drugs by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Table Asia-Pacific Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Abbott Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Biogen Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Merck Basic Information List Table AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table Company Basic Information List Table Company Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Neurotherapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company Neurotherapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Company Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Company Neurotherapeutic Drugs Volume in Other and Its Application Share Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Neurotherapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific Neurotherapeutic Drugs Sales Share by Players/Manufacturers Table Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Neurotherapeutic Drugs Revenue Market Share (%) Players Figure 2017 Asia-Pacific Neurotherapeutic Drugs Revenue Market Share (%) Players Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Sales Market Share by Regions in 2017 Table Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Revenue Market Share by Regions in 2017 Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Japan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Japan Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Japan Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Japan Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Korea Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table South Korea Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Korea Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South Korea Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South Korea Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Taiwan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Taiwan Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Taiwan Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Taiwan Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure India Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure India Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table India Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure India Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Australia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Australia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Australia Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Australia Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Australia Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Australia Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Australia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Australia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific Neurotherapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific Neurotherapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific Neurotherapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific Neurotherapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck